The Hong Kong
Neuro-Oncology Society
香港神經腫瘤學會

A charitable institution under Section 88 of the Inland Revenue Ordinance, Hong Kong Special Administrative Region

An organization to improve the standard of care and well-being of patients suffering from tumours of the nervous system in Hong Kong
Local Research & Publications
日期 作者 題目 DOI 下載
18/01/2023 Peter Y. M. Woo, Tiffany H. P. Law, Kelsey K. Y. Lee, Joyce S. W. Chow, Lai-Fung Li, Sarah S. N. Lau, Tony K. T. Chan, Jason M. K. Ho, Michael W. Y. Lee, Danny T. M. Chan & Wai-Sang Poon Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study https://doi.org/10.1080/02688697.2023.2167931 -
10/09/2022 Peter Y M Woo, Stephen Yau, Tai-Chung Lam, Jenny K S Pu, Lai-Fung Li, Louisa C Y Lui, Danny T M Chan, Herbert H F Loong, Michael W Y Lee, Rebecca Yeung, Carol C H Kwok, Siu-Kie Au, Tze-Ching Tan, Amanda N C Kan, Tony K T Chan, Calvin H K Mak, Henry K F Mak, Jason M K Ho, Ka-Man Cheung, Teresa P K Tse, Sarah S N Lau, Joyce S W Chow, Aya El-Helali, Ho-Keung Ng, Wai-Sang Poon Patterns of Care and Survival of Chinese Glioblastoma Patients in the Temozolomide Era: A Hong Kong Population-Level Analysis over a 14-year Period http://dx.doi.org/10.1093/nop/npac069 -
11/07/2012 Jenny K.S. Pu, Gloria K.B. Ng, Gilberto K.K. Leung, Chi-Keung Wong One-year review of the incidence of brain tumours in Hong Kong Chinese patients as part of the Hong Kong Brain and Spinal Tumours Registry 10.1111/j.1744-1633.2012.00616.x -
02/12/2016 Danny TM Chan, FRCS, FHKAM (Surgery); Sonia YP Hsieh, MB, BS, MSc; Claire KY Lau, MSc; Michael KM Kam, FRCR, FHKAM (Radiology); Herbert HF Loong, MB, BS, MRCP (UK); WK Tsang, FRCR, FHKAM (Radiology); Darren MC Poon, FRCR, FHKAM (Radiology); WS Poon, FRCS, FHKAM (Surgery) Ten-year review of survival and management of malignant glioma in Hong Kong 10.12809/hkmj164879 -
17/04/2018 Peter Woo, Jason Ho, SandyLam, Eric Ma, Danny Chan, Wai-Kei Wong, Calvin Mak, Michael Lee, Sui-To Wong, Kwong-Yau Chan, Wai-Sang Poon A Comparative Analysis of the Usefulness of Survival Prediction Models for Patients with Glioblastoma in the Temozolomide Era: The Importance of Methylguanine Methyltransferase Promoter Methylation, Extent of Resection, and Subventricular Zone Location 10.1016/j.wneu.2018.04.059 -
24/04/2020 Herbert H-F.Loong, Aliss MWong, Danny T-M.Chand, Maggie S-H.Cheung, Chit Chow, Xiaofan Ding, Aden K-Y.Chan, Paul A.Johnston, James Y-W.Lau, Wai SangPoon, Nathalie Wong Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy? 10.1016/j.jocn.2020.04.107 -
27/06/2019 Peter Y. M. Woo, Yi Li, Anna H. Y. Chan, Stephanie C. P. Ng, Herbert H. F. Loong, Danny T. M. Chan, George K. C. Wong, Wai-Sang Poon A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferase 10.21037/apm.2018.10.02 -
17/09/2018 Tai Chung Lam, Yolanda Tseng Defining the radiation oncologist’s role in palliative care and radiotherapy 10.21037/apm.2018.10.02 -
15/05/2017 Tai-Chung Lam, Arjun Sahgal, Simon S. Lo, Eric L. Chang An update on radiation therapy for brain metastases 10.21037/cco.2017.06.02 -
17/10/2020 Ho-Keung Ng, Aden Ka-Yin Chan, Nim-Chi Amanda Kan, Dennis Tak-Loi Ku, Danny Tat-Ming Chan, Kay Ka-Wai Li To do genomics or not do? This is the question 10.4103/glioma.glioma_22_20 -
Noteworthy Journal Updates
日期 作者 題目 DOI 下載
08-08-2021 Patrick Y Wen, Roger J Packer The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications 10.1093/neuonc/noab120 -
目標
01
To promote education and exchange of knowledge in the fields of tumours of the nervous system.
02
To facilitate research for improving the knowledge of tumours of the nervous system.
03
To endeavor to improve the standard of care for patients with tumours of the nervous system.
04
To provide a means of liaison with persons or organisations involved in the treatment of tumours of the nervous system in other parts of the world.
05
To organise scientific and social meetings in order to encourage interchange of knowledge and to stimulate co-operation in the management, control and treatment of tumours of the nervous system.
理事會成員
Established in 2011, with members comprising oncologists, pathologists, radiologists, and neurosurgeons.
President
Neurosurgeon
Dr. Aya El Helali
First Vice-President
Dr. Calvin Mak
(麥凱鈞醫生)
Second Vice-President
Neuro-oncologist
Dr. Jason Ho
(何文傑醫生)
Treasurer
Neurosurgeon
Dr. Peter YM Woo
(胡日明醫生)
Secretary
Neuro-oncologist
Dr. Joyce Chow
(鄒淑韻醫生)
Council Members

Dr. Stephen Yau (丘德芬醫生)

Neuro-oncologist

Dr. Rebecca Yeung(楊美雲醫生)

Neuro-oncologist

Dr. Carol CH Kwok(郭子熹醫生)

Neuro-oncologist

Prof. Herbert HF Loong(龍浩鋒教授)

Neuro-oncologist

Dr. SK Au(區兆基醫生)

Neuro-oncologist

Dr. Ken KM Cheung(張嘉文醫生)

Neuro-oncologist

Dr. Louisa CY Lui(呂卓如醫生)

Neuro-oncologist

Dr. TC Tan(陳智勤醫生)

Neurosurgeon

Dr. Michael WY Lee(李永恩醫生)

Neurosurgeon

Dr. Tony KT Chan(陳甘棠醫生)

Neurosurgeon

Dr. LF Li(李禮峰醫生)

Neurosurgeon

Dr. Amanda NC Kan(簡念慈醫生)

Neuro-pathologist

Advisors

Dr Jenny KS Pu(浦勤孫醫生)

Neurosurgeon

Dr. TC Lam(林泰忠醫生)

Neuro-oncologist

Dr. Henry KF Mak(麥嘉豐醫生)

Neuro-radiologist

Webmaster

Dr. Jason Ho(何文傑醫生)

Neurosurgeon

  1. A Board of 15 people from different backgrounds and professions. The role is to overlook the running of the society, the projects/events initiated by the Society and financial expenses.
  2. Council: 1 President, 2 Vice Presidents, 1 Treasurer, 1 Secretary and 10 Council Members
  3. Member: any healthcare professional interested in Neurooncology
Membership
Full Members

Any medical practitioner normally residing in Hong Kong who has an interest in tumours of the nervous system shall be eligible for application to be admitted as a full member of the Society upon the written recommendation of two full members of the Society.

All applications for full membership are subject to approval by the Council. Full member has voting right and shall be eligible for election to office.

Associate Members

Any person who is involved in the study or care of patients with tumours of the nervous system but is not qualified to be registered as a medical practitioner or not normally residing in Hong Kong shall be eligible for application to be admitted as an associate member of the Society upon the written recommendation of two full members of the Society, or one full member and one associate member.

All applications are subject to approval by the Council. Associate members shall have no voting rights and shall not be eligible for election to office.

Honory Members

The Council may recommend at the annual General Meeting distinguished persons in the field of tumours of the nervous system or persons or corporations who have in the opinion of the Council made great contributions to the Society to become honorary members.

Honorary members shall have no voting rights and shall not be eligible for election to office.

No subscription fee will be levied at present.
CONTACT US